Summary
Carmot Therapeutics
Founded in 2008
Description
Carmot Therapeutics is a clinical stage biotechnology company that is focused on the discovery and development of disease modifying therapies for people living with metabolic diseases including obesity and diabetes.
Strengths
- Carmot Therapeutics has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Revenue growth is more steady than the industry average
- Since Carmot Therapeutics was founded, the company has grown faster than the industry average
Annual Revenue
Carmot Therapeutics's annual revenue
$14058000
Based on Kona Equity data
-
Revenue per employee
$702900
-
Variance of revenue growth
0.02
-
Annual revenue growth since founding
$930285
-
Revenue growth rate from first known quarter to current
22.9%
Employee Count
20 employees
-
Employee growth rate from first known quarter to current
18.9%
Executives
James Watson
Chief Business Officer
j**@carmot-therapeutics.usJennifer Rojas
Scientist II, In Vivo Pharmacology
j**@carmot-therapeutics.usDavid Lloyd
Senior Director Pharmacology and Translational Biology
d**@carmot-therapeutics.usStig Hansen
Co-Founder & Chief Executive Officer
s**@carmot-therapeutics.usRohit Sarna
Corporate Controller
r**@carmot-therapeutics.usAlec Elliott
Clinical Operations Intern
a**@carmot-therapeutics.usHeather Turner
Chief Operating Officer
h**@carmot-therapeutics.usMichael Elliott
Vice President, Clinical Operations
m**@carmot-therapeutics.usXiaohui Du
Director, Head of Medicinal Chemistry
x**@carmot-therapeutics.usDavid Schubert
Senior VP, Regulatory & Quality
d**@carmot-therapeutics.usG Score - 6
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G5 Variance of revenue growth is less than the industry average
- G6 Annual revenue growth since founding is higher than the industry average.
Location
Unlock unlimited leads
Similar Companies
Alkahest Inc
alkahest.com- Founded in 2014
- Location: San Carlos, CA
- Annual Revenue: $17.6M
- Employees: 44
- Alkahest is a clinical stage biopharmaceutical company focused on treating neurodegenerative and other age-related diseases. They develop transformative therapies derived from a deep understanding of the plasma proteome in aging and disease. Their rese...
Compass Therapeutics
compasstherapeutics.com- Founded in 2014
- Location: Boston, MA
- Annual Revenue: $5.1M
- Employees: 24
- Compass Therapeutics is a clinical stage biopharmaceutical company focused on developing antibody-based therapeutics to treat multiple human diseases. Their scientific focus is on the relationship between angiogenesis, the immune system, and tumor grow...
Galera Therapeutics, Inc.
galeratx.com- Founded in 2009
- Location: Malvern, PA
- Annual Revenue: $6.3M
- Employees: 30
- This is the home page.
Metacrine Inc
metacrine.com- Founded in 2014
- Location: San Diego, CA
- Annual Revenue: $5.7M
- Employees: 17
- We are an experienced team with internal drug discovery and development expertise focused on building a pipeline of best-in-class oral drugs for liver and gastrointestinal diseases.
PhaseBio Pharmaceuticals
phasebio.com- Founded in 2002
- Location: Malvern, PA
- Annual Revenue: $10.9M
- Employees: 60
- PhaseBio is focused on the development and commercialization of novel therapies to treat orphan diseases, with an initial focus on cardiopulmonary indications.
Visterra , Inc.
visterrainc.com- Founded in 2007
- Location: Waltham, Massachusetts
- Annual Revenue: $18.9M
- Employees: 53
- Visterra is a biologics research and early stage clinical development company developing therapies for patients with immune mediated and other hard to treat diseases. Our proprietary technology platform enables the design and engineering of precision a...
Key Information
- Name: Carmot Therapeutics
- Category: Biotechnology
- Industry: Biotechnology Company
- SIC: 80; 283
- NAICS: 5417; 541
See similar companies
-
By City San Francisco Small Biotechnology Company in San Francisco Mid-size Biotechnology Company in San Francisco Biotechnology in San Francisco Small Biotechnology in San Francisco Mid-size Biotechnology in San Francisco
-
By State CA Small companies in CA Biotechnology in CA Small Biotechnology in CA Mid-size Biotechnology in CA Small Biotechnology Company in CA Mid-size Biotechnology Company in CA
-
By Category Biotechnology Small Biotechnology Mid-size Biotechnology
-
By Industry Biotechnology Company Small Biotechnology Company Mid-size Biotechnology Company Biotechnology and Biotechnology Company
-
Firmographic data G Score of 6 Founded in 2008 SIC: 80 SIC: 283 NAICS: 5417 NAICS: 541 #Biotechnology #Pharmaceuticals #Healthcare
Frequently Asked Questions
Carmot Therapeutics's headquarters are located at 409 Illinois St San Francisco, CA 94158.
Carmot Therapeutics's official website is carmot-therapeutics.us
Carmot Therapeutics's annual revenue is $14.1 M.
Carmot Therapeutics's SIC: 80; 283
Carmot Therapeutics's NAICS: 5417; 541.
Carmot Therapeutics has 20 employees
Carmot Therapeutics is in the industry of Biotechnology.
